Koun H Lee

Title: Koun H Lee - Innovator in Antibacterial Cephalosporin Derivatives

Introduction

Koun H Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibacterial agents. His work focuses on cephalosporin derivatives, which are crucial in combating bacterial infections.

Latest Patents

Koun H Lee holds a patent for "3-fused pyridiniummethyl cephalosporins." This patent describes novel semi-synthetic cephalosporin derivatives that feature a fused pyridiniummethyl group at the 3-position of the cephem nucleus. The patent also covers pharmaceutically acceptable salts, physiologically hydrolizable esters, or solvates of these compounds. The innovative process for preparing these cephalosporin derivatives involves introducing a fused pyridiniummethyl substituent at the 3-position of specific 7-.beta.-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-cephem-carboxylic acid derivatives. The compounds developed under this patent exhibit potent antibacterial activities and a broad spectrum of effectiveness against both gram-positive and gram-negative bacteria.

Career Highlights

Koun H Lee is associated with Cheil Foods & Chemicals, Inc., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in enhancing the efficacy of antibacterial treatments, contributing to public health.

Collaborations

He has collaborated with notable colleagues such as Choong S Kim and Seung Ho An, further enriching his research endeavors and expanding the impact of his inventions.

Conclusion

Koun H Lee's contributions to the field of antibacterial cephalosporin derivatives highlight his innovative spirit and dedication to improving healthcare solutions. His patent reflects a significant advancement in the fight against bacterial infections, showcasing the importance of continued research and development in pharmaceuticals.